Ph2 study of zelenecitide pevedotin in participants with NECTIN4 with mNSCLC
Phase II Clinical Trial
Phase 2 Study of Zelenectide Pevedotin in Participants with Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer (BT8009-202)
Participating Locations